According to Samsung Biologics 's latest financial reports the company's total liabilities are $4.80 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $4.80 B | -20.25% |
2022-12-31 | $6.02 B | 140.68% |
2021-12-31 | $2.50 B | 49% |
2020-12-31 | $1.68 B | 24.77% |
2019-12-31 | $1.34 B | -17.63% |
2018-12-31 | $1.63 B | -45.65% |
2017-12-31 | $3.00 B | 5.08% |
2016-12-31 | $2.86 B | 5.62% |
2015-12-31 | $2.71 B | 309.46% |
2014-12-31 | $0.66 B |